1.McArdle JJ, Lentz TL, Witzemann V, et al. Wagerlin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.J Pharmacol Exp Ther.1999;289:543–550.[PubMed][Google Scholar]
2.Burke KE. Interaction of vitamins C and E as better cosmeceuticals.Dermatol Ther.2007;20(5):314–321.[PubMed][Google Scholar]
3.Uitto J. The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure.J Drugs Dermatol.2008;7(2):S12–16.[PubMed][Google Scholar]
4. Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther. 2007;20(5):350–359. [PubMed] [Google Scholar]
5. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5:25–34. [PubMed] [Google Scholar]
6. Ehrlich M, Rao J, Pabby A, Goldman MP. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and 1-ascorbic acid. Dermatol Surg. 2006;32:618–625. [PubMed] [Google Scholar]
7. Gold MH, Goldman MP, Biron J. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol. 2007;6:197–201. [PubMed] [Google Scholar]
8. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000;11:59–69. [PubMed] [Google Scholar]
9. Varga J., Rosenbloom J, Jimenez SA. Transforming growth factor β (TGF-β) causes a persistent increase in steadystate amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J. 1987;247:597–604. [PMC free article] [PubMed] [Google Scholar]
10. Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles. J Clin Aesthet Dermatol. 2009 Mar; 2(3): 38-43.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923951/